These findings identify 25<i>R</i>-inokosterone as a promising multi-target natural lead for PD, which exerts antioxidant and anti-apoptotic effects predominantly by activating Nrf2, accompanied by the upstream modulation of MAOB/GSK-3β expression. Here, NFE2L2 is linked to Parkinson disease.